Carcinoma of the uterine cervix FIGO stage I-B

Leon L. Adcock, Thomas M. Julian, Takashi Okagaki, Thomas K. Jones, Konald A. Prem, Leo B. Twiggs, Roger A. Potish, George L. Phillips

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.

Original languageEnglish
Pages (from-to)199-208
Number of pages10
JournalGynecologic Oncology
Volume14
Issue number2
DOIs
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Cervix Uteri
Carcinoma
Adenosquamous Carcinoma
Papanicolaou Test
Survival Rate
Early Diagnosis
Adenocarcinoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Adcock, L. L., Julian, T. M., Okagaki, T., Jones, T. K., Prem, K. A., Twiggs, L. B., ... Phillips, G. L. (1982). Carcinoma of the uterine cervix FIGO stage I-B. Gynecologic Oncology, 14(2), 199-208. https://doi.org/10.1016/0090-8258(82)90090-7

Carcinoma of the uterine cervix FIGO stage I-B. / Adcock, Leon L.; Julian, Thomas M.; Okagaki, Takashi; Jones, Thomas K.; Prem, Konald A.; Twiggs, Leo B.; Potish, Roger A.; Phillips, George L.

In: Gynecologic Oncology, Vol. 14, No. 2, 01.01.1982, p. 199-208.

Research output: Contribution to journalArticle

Adcock, LL, Julian, TM, Okagaki, T, Jones, TK, Prem, KA, Twiggs, LB, Potish, RA & Phillips, GL 1982, 'Carcinoma of the uterine cervix FIGO stage I-B', Gynecologic Oncology, vol. 14, no. 2, pp. 199-208. https://doi.org/10.1016/0090-8258(82)90090-7
Adcock LL, Julian TM, Okagaki T, Jones TK, Prem KA, Twiggs LB et al. Carcinoma of the uterine cervix FIGO stage I-B. Gynecologic Oncology. 1982 Jan 1;14(2):199-208. https://doi.org/10.1016/0090-8258(82)90090-7
Adcock, Leon L. ; Julian, Thomas M. ; Okagaki, Takashi ; Jones, Thomas K. ; Prem, Konald A. ; Twiggs, Leo B. ; Potish, Roger A. ; Phillips, George L. / Carcinoma of the uterine cervix FIGO stage I-B. In: Gynecologic Oncology. 1982 ; Vol. 14, No. 2. pp. 199-208.
@article{a17a9ca4d8cf463d88edb67bc955340c,
title = "Carcinoma of the uterine cervix FIGO stage I-B",
abstract = "All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3{\%}, the corrected rate being 80.8{\%}. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.",
author = "Adcock, {Leon L.} and Julian, {Thomas M.} and Takashi Okagaki and Jones, {Thomas K.} and Prem, {Konald A.} and Twiggs, {Leo B.} and Potish, {Roger A.} and Phillips, {George L.}",
year = "1982",
month = "1",
day = "1",
doi = "10.1016/0090-8258(82)90090-7",
language = "English",
volume = "14",
pages = "199--208",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Carcinoma of the uterine cervix FIGO stage I-B

AU - Adcock, Leon L.

AU - Julian, Thomas M.

AU - Okagaki, Takashi

AU - Jones, Thomas K.

AU - Prem, Konald A.

AU - Twiggs, Leo B.

AU - Potish, Roger A.

AU - Phillips, George L.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.

AB - All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0019907058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019907058&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(82)90090-7

DO - 10.1016/0090-8258(82)90090-7

M3 - Article

VL - 14

SP - 199

EP - 208

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -